Skip to content
RxLibra
  • Home
  • NEWS
    • NewsRoom
    • TradeKown
    • PRsources
  • Community
  • Product
    • PIPELINE
    • MITODX
  • About
    • FSDL
    • Contact
  • Copyright
RxLibra
  • Home
  • NEWS
    • NewsRoom
    • TradeKown
    • PRsources
  • Community
  • Product
    • PIPELINE
    • MITODX
  • About
    • FSDL
    • Contact
  • Copyright

Categories:

PIPELINE

4 kinds of targeted therapies for the treatment of ROS1-positive non-small cell lung cancer

RxLibra /
October 3, 2022 /
0 comment(s)
About Non Small Cell Lung Carcinoma (NSCLC) Non-small-cell lung carcinoma (NSCLC) is any type of epithelial lung cancer other than small-cell lung carcinoma (SCLC). NSCLC accounts for about 85% of all lung cancers. As a class, NSCLCs are relatively insensitive to chemotherapy, compared to small-cell […]
read more
Recent Posts
  • 2025 Make cost-effectiveness more accessible in Southeast Asian
  • Double “0” breakthrough! Laos BIGBEAR Pharmaceutical’s anti-cancer drugs are exported to ASEAN economies for the first time
  • How to quote for international trade?
  • RxLibra P2P Exchange Community-Recruit community members
  • How to inquire about the product registration information of Lao pharmaceutical companies?
Recent Comments
    Archives
    • December 2024
    • September 2024
    • March 2024
    • February 2024
    • August 2023
    • October 2022
    • September 2022
    • August 2022
    • June 2022
    • May 2022
    Categories
    • NEWs
    • PIPELINE
    • TradeKown
    © 2025 RxLibra. Created for free using WordPress and Colibri